0 results available. Select is focused ,type to refine list, press Down to open the menu,
H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and inter...
The following section summarizes insights on H. Lundbeck A/S's Avg EBIT Margin Forecast (5y):
We've identified the following companies as similar to H. Lundbeck A/S because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Avg EBIT Margin Forecast (5y) |
|---|---|---|
| Healthcare | SECTOR:HLTH.DK | -137.5% |
| Almirall | BME:ALM | 12.2% |
| H. Lundbeck A/S | DB:LDBB | 20.2% |
| Orion Oyj | DB:OFK | 28.5% |
| Sanofi SA | ENXTPA:SAN | 29.2% |
| UCB SA | DB:UNC | 29.7% |
| GSK plc | DB:GS71 | 30.8% |
| Pfizer Inc | DB:PFE | 34.2% |
| AstraZeneca | DB:ZEG | 35.2% |
| Roche Holding AG | SWX:RO | 36.1% |
| Novartis AG | SWX:NOVN | 39.5% |
| Novo Nordisk A/S | BRSE:NOVOB | 47.3% |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Avg EBIT Margin Forecast (5y) in the forecast category include:
Five year average forecasted earnings before interest and taxes (EBIT) margin.